Ascend Wellness Holdings (AAWH) Liabilities and Shareholders Equity (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Liabilities and Shareholders Equity came in at $872.1 million in Q1 2026, down 4.87% year-on-year from $916.7 million in Q1 2025, and down 3.95% quarter-over-quarter from $907.9 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Liabilities and Shareholders Equity history runs 7 years deep, the most recent figure standing at $872.1 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 4.87% year-over-year to $872.1 million in Q1 2026; TTM through Mar 2026 was $2.7 billion, a 26.3% decrease from a year earlier, with the FY2025 full-year figure at $907.9 million, up 0.83% from the prior year.
  • Liabilities and Shareholders Equity retreated to $872.1 million in Q1 2026 per AAWH's latest filing, from $907.9 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $929.4 million in Q2 2024 and bottomed at $407000.0 in Q3 2025.
  • The 5-year median for Liabilities and Shareholders Equity is $899.6 million (2023), against an average of $829.9 million.
  • Across the five-year window, Liabilities and Shareholders Equity surged 48.39% in 2022 and sank 99.95% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $872.2 million in 2022, then rose by 5.43% to $919.6 million in 2023, then decreased by 2.08% to $900.4 million in 2024, then increased by 0.83% to $907.9 million in 2025, then fell by 3.95% to $872.1 million in 2026.
  • Per Business Quant, the three latest AAWH Liabilities and Shareholders Equity figures stand at $872.1 million (Q1 2026), $907.9 million (Q4 2025), and $407000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 43.40 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 40.04 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 15.15 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 98.91 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 6.71 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 69.30 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 36.83 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 4.91 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.22 Bn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn 872.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 872.09 Mn
Dec 31, 2025 907.93 Mn
Sep 30, 2025 407,000.00
Jun 30, 2025 903.87 Mn
Mar 31, 2025 916.73 Mn
Dec 31, 2024 900.43 Mn
Sep 30, 2024 895.87 Mn
Jun 30, 2024 929.36 Mn
Mar 31, 2024 921.86 Mn
Dec 31, 2023 919.55 Mn
Sep 30, 2023 907.99 Mn
Jun 30, 2023 899.56 Mn
Mar 31, 2023 870.09 Mn
Dec 31, 2022 872.16 Mn
Sep 30, 2022 847.21 Mn
Jun 30, 2022 828.79 Mn
Mar 31, 2022 714.20 Mn
Dec 31, 2021 723.44 Mn
Sep 30, 2021 716.88 Mn
Jun 30, 2021 578.76 Mn